[1]
Tyagi, N. et al. 2023. A Prospective, Observational and Comparative Study of In-Vitro Susceptibility of Isepamicin against Clinical Isolates from Various Clinical Sources (Triple I Study - Isepamicin in India). Journal of Drug Delivery and Therapeutics. 13, 9 (Sep. 2023), 49–54. DOI:https://doi.org/10.22270/jddt.v13i9.6188.